Viewing nowCombinationARB-Xg 10/160 Milligrams
Valsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.

MFDS item code 201308548 · Approved 2013.07.31 · Insurance code 647803840
Improvement of blood pressure control in essential hypertension when combined with amlodipine and valsartan
In patients with essential hypertension, when blood pressure control is insufficient with monotherapy of amlodipine or valsartan alone, this medication can help achieve better blood pressure control. This contributes to stable management of blood pressure, reducing the risk of complications and improving health.
The recommended dose for this medication is 1 tablet once a day, taken with water regardless of food intake. It is advised to take it at the same time every day (e.g., in the morning). Patients with kidney impairment: Dose adjustment is not required for mild to moderate kidney impairment (creatinine clearance above 10 mL/min). Patients with severe kidney impairment or on dialysis should not take this medication. Patients with liver impairment: Mild and moderate liver impairment.
The safety and efficacy of this medication in pediatric patients under 18 years have not been established, so its use is not recommended.
This medication can cause severe harm to the fetus when taken during pregnancy, especially in the second and third trimesters, so it must be discontinued immediately if pregnancy is confirmed. People who are allergic to the ingredients in this medication or similar drugs, pregnant or breastfeeding women, patients with severe kidney or liver disease, and patients with specific heart conditions should not take this medication. Patients with sodium or fluid depletion must correct their condition before taking this medication. If symptoms of hypotension occur while taking this medication, appropriate measures should be taken immediately. Patients with high potassium levels should take caution when using this medication alongside potassium supplements or potassium-sparing diuretics, and blood potassium levels should be regularly monitored. Patients with renal vascular issues or those who have received a kidney transplant require careful monitoring by a physician as this medication may affect kidney function. If symptoms of angioedema, such as swelling of the face, lips, or tongue, occur while taking this medication, it should be stopped immediately and not resumed. Patients with heart failure or following myocardial infarction should have regular tests to consider the possibility of changes in kidney function and hypotension while taking this medication. This medication may interact with other antihypertensive medications or drugs, so it is essential to inform healthcare providers of any other medications being taken. Caution is advised while driving or operating machinery as dizziness or fatigue may occur. Elderly patients may be prescribed a dosage similar to that of regular adults, but adjustments may be needed based on their physical condition. Children under 18 years of age are not recommended for this medication as its safety and efficacy have not been adequately established. In cases of overdose, severe hypotension or cardiovascular abnormalities may occur, so it is vital to adhere to the prescribed dose and visit a medical institution immediately if abnormal symptoms arise. It is important to regularly check blood pressure, kidney function, and electrolyte levels while taking this medication to confirm any abnormalities.
Hives, severe swelling (edema), angioedema, chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rashes with high fever, blisters, skin peeling, pain in oral/conjunctival mucosa, severe skin abnormal reactions, shortness of breath or difficulty breathing, asthma attack, respiratory problems with cough and fever, yellowing of the skin or eyes (jaundice), extreme lethargy, liver abnormalities (jaundice), sudden and
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. The recommended storage temperature is at room temperature between 1 to 30 degrees Celsius.
Bright yellow oval film-coated tablets
28 tablets (14 tablets/PTP*2), 30 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Samjin Pharmaceutical Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
CombinationValsartan 80mg · Amlodipine Besylate 6.94mg
Tablet · Prescription medication · Combination
Korea Novartis Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Novartis Korea Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandose Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
Valsartan · Amlodipine Besylate
Prescription medication · Combination
Korea Sandos Co., Ltd.
CombinationValsartan 160mg · Amlodipine Besylate 13.87mg
Tablet · Prescription medication · Combination
Myungmoon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.